These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 3932629

  • 1. Intraperitoneal deferoxamine therapy for aluminum intoxication in a child undergoing continuous ambulatory peritoneal dialysis.
    Andreoli SP, Dunn D, DeMyer W, Sherrard DJ, Bergstein JM.
    J Pediatr; 1985 Nov; 107(5):760-3. PubMed ID: 3932629
    [No Abstract] [Full Text] [Related]

  • 2. [Chronic aluminum poisoning in continuous ambulatory peritoneal dialysis: treatment with deferoxamine].
    Passlick J, Wilhelm M, Busch T, Grabensee B, Ohnesorge FK.
    Dtsch Med Wochenschr; 1989 Feb 17; 114(7):253-7. PubMed ID: 2917487
    [Abstract] [Full Text] [Related]

  • 3. Aluminum intoxication in a child: treatment with intraperitoneal desferrioxamine.
    Warady BA, Ford DM, Gaston CE, Sedman AB, Huffer WE, Lum GM.
    Pediatrics; 1986 Oct 17; 78(4):651-5. PubMed ID: 3763276
    [Abstract] [Full Text] [Related]

  • 4. Microcytic anemia in dialysis patients: reversible marker of aluminum toxicity.
    Swartz R, Dombrouski J, Burnatowska-Hledin M, Mayor G.
    Am J Kidney Dis; 1987 Mar 17; 9(3):217-23. PubMed ID: 3826071
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Aluminum-related osteomalacia in renal-failure patients.
    Vick KE, Johnson CA.
    Clin Pharm; 1985 Mar 17; 4(4):434-9. PubMed ID: 3899471
    [Abstract] [Full Text] [Related]

  • 9. Clearance of aluminum by hemodialysis: effect of desferrioxamine.
    Milliner DS, Hercz G, Miller JH, Shinaberger JH, Nissenson AR, Coburn JW.
    Kidney Int Suppl; 1986 Feb 17; 18():S100-3. PubMed ID: 3457984
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Changes of metal concentrations in blood and peritoneal dialysate during long-term desferrioxamine B therapy.
    Romero RA, Salgado O, Elejalde LE, Rodríguez-Iturbe B, Tahán JE.
    Transplant Proc; 1996 Dec 17; 28(6):3385-7. PubMed ID: 8962321
    [No Abstract] [Full Text] [Related]

  • 12. [Desferrioxamine treatment of osteomalacia caused by aluminum poisoning].
    Charhon SA, Chavassieux P, Chapuy MC, Accominotti M, Traeger J, Meunier PJ.
    Presse Med; 1986 Jan 18; 15(2):55-9. PubMed ID: 2935857
    [Abstract] [Full Text] [Related]

  • 13. Deferoxamine for aluminum toxicity in dialysis patients.
    Hernandez P, Johnson CA.
    ANNA J; 1990 Jun 18; 17(3):224-8. PubMed ID: 2357118
    [Abstract] [Full Text] [Related]

  • 14. The use of intravenous and intraperitoneal desferrioxamine in aluminium osteomalacia.
    O'Brien AA, McParland C, Keogh JA.
    Nephrol Dial Transplant; 1987 Jun 18; 2(2):117-9. PubMed ID: 3112649
    [Abstract] [Full Text] [Related]

  • 15. Therapy of aluminium overload (II).
    Ackrill P, Day JP.
    Contrib Nephrol; 1984 Jun 18; 38():78-80. PubMed ID: 6713902
    [No Abstract] [Full Text] [Related]

  • 16. Therapy of aluminum overload (I).
    Pierides AM, Myli MP.
    Contrib Nephrol; 1984 Jun 18; 38():65-77. PubMed ID: 6425013
    [No Abstract] [Full Text] [Related]

  • 17. Deferoxamine and aluminum removal.
    Swartz RD.
    Am J Kidney Dis; 1985 Nov 18; 6(5):358-64. PubMed ID: 3904429
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Iron removal during continuous ambulatory peritoneal dialysis using deferoxamine.
    Falk RJ, Mattern WD, Lamanna RW, Gitelman HJ, Parker NC, Cross RE, Rastall JR.
    Kidney Int; 1983 Jul 18; 24(1):110-2. PubMed ID: 6620847
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.